Essex Bio-Technology Limited

SEHK:1061 Stok Raporu

Piyasa değeri: HK$1.5b

Essex Bio-Technology Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 3/6

Essex Bio-Technology yıllık ortalama 0.01% oranında kazançlarını artırırken, Biotechs sektöründe kazançlar growing at 31.7% annual. Gelirler growing yılda ortalama 8.5% oranında artmaktadır. Essex Bio-Technology'in özkaynak karlılığı 13% ve net marjı 16.2%'dir.

Anahtar bilgiler

0.005%

Kazanç büyüme oranı

0.3%

EPS büyüme oranı

Biotechs Sektör Büyümesi11.0%
Gelir büyüme oranı8.5%
Özkaynak getirisi13.0%
Net Marj16.2%
Son Kazanç Güncellemesi30 Jun 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Essex Bio-Technology Limited (HKG:1061) Surges 29% Yet Its Low P/E Is No Reason For Excitement

Oct 09
Essex Bio-Technology Limited (HKG:1061) Surges 29% Yet Its Low P/E Is No Reason For Excitement

Essex Bio-Technology's (HKG:1061) Upcoming Dividend Will Be Larger Than Last Year's

Aug 29
Essex Bio-Technology's (HKG:1061) Upcoming Dividend Will Be Larger Than Last Year's

Essex Bio-Technology Limited's (HKG:1061) Low P/E No Reason For Excitement

May 06
Essex Bio-Technology Limited's (HKG:1061) Low P/E No Reason For Excitement

Calculating The Fair Value Of Essex Bio-Technology Limited (HKG:1061)

Mar 21
Calculating The Fair Value Of Essex Bio-Technology Limited (HKG:1061)

Essex Bio-Technology (HKG:1061) Has A Pretty Healthy Balance Sheet

Dec 07
Essex Bio-Technology (HKG:1061) Has A Pretty Healthy Balance Sheet

Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly

Dec 07
Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly

Essex Bio-Technology (HKG:1061) Is Due To Pay A Dividend Of HK$0.04

Aug 25
Essex Bio-Technology (HKG:1061) Is Due To Pay A Dividend Of HK$0.04

Is Essex Bio-Technology (HKG:1061) Using Too Much Debt?

Jun 22
Is Essex Bio-Technology (HKG:1061) Using Too Much Debt?

Essex Bio-Technology (HKG:1061) Has Announced That It Will Be Increasing Its Dividend To HK$0.055

May 02
Essex Bio-Technology (HKG:1061) Has Announced That It Will Be Increasing Its Dividend To HK$0.055

Essex Bio-Technology (HKG:1061) Will Pay A Larger Dividend Than Last Year At HK$0.055

Mar 30
Essex Bio-Technology (HKG:1061) Will Pay A Larger Dividend Than Last Year At HK$0.055

Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly

Jun 29
Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly

Is Essex Bio-Technology (HKG:1061) A Risky Investment?

Mar 31
Is Essex Bio-Technology (HKG:1061) A Risky Investment?

If You Had Bought Essex Bio-Technology (HKG:1061) Stock Five Years Ago, You Could Pocket A 40% Gain Today

Mar 13
If You Had Bought Essex Bio-Technology (HKG:1061) Stock Five Years Ago, You Could Pocket A 40% Gain Today

How Many Essex Bio-Technology Limited (HKG:1061) Shares Did Insiders Buy, In The Last Year?

Feb 15
How Many Essex Bio-Technology Limited (HKG:1061) Shares Did Insiders Buy, In The Last Year?

Do Institutions Own Essex Bio-Technology Limited (HKG:1061) Shares?

Jan 25
Do Institutions Own Essex Bio-Technology Limited (HKG:1061) Shares?

Essex Bio-Technology Limited's (HKG:1061) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?

Jan 04
Essex Bio-Technology Limited's (HKG:1061) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?

Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly

Dec 13
Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly

Why Essex Bio-Technology's (HKG:1061) CEO Pay Matters

Nov 23
Why Essex Bio-Technology's (HKG:1061) CEO Pay Matters

Gelir ve Gider Dağılımı

Essex Bio-Technology nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

SEHK:1061 Gelir, gider ve kazançlar (HKD Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 241,6192631,1600
31 Mar 241,6632691,1950
31 Dec 231,7072751,2290
30 Sep 231,6342661,1610
30 Jun 231,5612561,0930
31 Mar 231,4392411,0030
31 Dec 221,3182259140
30 Sep 221,4372749500
30 Jun 221,5563239870
31 Mar 221,5973349880
31 Dec 211,6383469900
30 Sep 211,5153399080
30 Jun 211,3923328250
31 Mar 211,1852757070
31 Dec 209782195880
30 Sep 201,0002215890
30 Jun 201,0222225890
31 Mar 201,1512626520
31 Dec 191,2793037150
30 Sep 191,2382827150
30 Jun 191,1972627160
31 Mar 191,1872467170
31 Dec 181,1762317190
30 Sep 181,1002106730
30 Jun 181,0231896280
31 Mar 189611785920
31 Dec 179001675560
30 Sep 178741595280
30 Jun 178491515000
31 Mar 178131444790
31 Dec 167761364580
30 Sep 167401264460
30 Jun 167051154340
31 Mar 166791104190
31 Dec 156541054030
30 Sep 156271013790
30 Jun 15600963550
31 Mar 15559863340
31 Dec 14518753140
30 Sep 14466672950
30 Jun 14413592750
31 Mar 14380572560
31 Dec 13347552380

Kaliteli Kazançlar: 1061 yüksek kaliteli kazançlar sağlıyor.

Büyüyen Kar Marjı: 1061 'nin mevcut net kar marjları (16.2%) geçen yılın (16.4%) değerinden daha düşüktür.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 1061 şirketinin kazancı son 5 yılda yılda 0.01% oranında arttı.

Büyüme Hızlandırma: 1061 'un son bir yıldaki kazanç büyümesi ( 2.7% ) 5 yıllık ortalamasını (yıllık 0.01% ) aşıyor.

Kazançlar vs. Sektör: 1061 geçen yılki kazanç büyümesi ( 2.7% ) Biotechs sektörünün 4% performansını geride bırakmadı.


Özkaynak Getirisi

Yüksek ROE: 1061 'nin Özsermaye Getirisi ( 13% ) düşük olarak değerlendiriliyor.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin